Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Alaris Medical

This article was originally published in The Gray Sheet

Executive Summary

Alaris Medical: San Diego-based infusion products firm says it is "proceeding with negotiations" regarding a dispute over its maquiladora manufacturing facilities in Tijuana, Mexico. The dispute is with Cal Pacifico, a Newport Beach, California contractor of maquiladora manufacturing services through which Alaris manufactures its products at two Tijuana plants under a "shelter" arrangement. Alaris says it notified Cal Pacifico in April that it would terminate the shelter program Aug. 1 and would take over its own manufacturing operation in Mexico. On June 11, five days after Alaris hired workers at the two plants, Cal Pacifico expelled all Alaris personnel from the facilities, thereby halting production. Alaris says it is ramping up manufacturing activities at its sites in San Diego, North Carolina, and Europe to address the shut down in Mexican operations and is "working diligently with Mexican authorities" to resume manufacturing in that country. The firm notes that it "does not anticipate that the dispute will have an impact on customers or results of its operations for the second quarter"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel